Growth conditions of clostridium perfringens type B for production of toxins used to obtain veterinary vaccines

Bioprocess Biosyst Eng. 2014 Sep;37(9):1737-42. doi: 10.1007/s00449-014-1146-0. Epub 2014 Feb 27.

Abstract

The diseases caused for Clostridium perfringens are generically called enterotoxemias because toxins produced in the intestine may be absorbed into the general circulation. C. perfringens type B, grown in batch fermentation, produced toxins used to obtain veterinary vaccines. Glucose in concentrations of 1.4-111.1 mM was used to define the culture medium. The minimum concentration for a satisfactory production of vaccines against clostridial diseases was 55.6 mM. Best results were brought forth by meat and casein peptones, both in the concentration 5.0 g l(-1) in combination with glucose and a culture pH maintained at 6.5 throughout the fermentation process. The production of lactic, acetic and propionic organic acids was observed. Ethanol was the metabolite produced in the highest concentration when cultures maintained steady pH of 6.5 with exception of cultures with initial glucose concentration of 1.4 mM, where the highest production was of propionic acid. Maximal cell concentration and the highest toxin title concomitantly low yield coefficient to organic acids and ethanol were obtained using basal medium containing 111.1 mM glucose under a controlled pH culture (pH) 6.5 in batch fermentations of C. perfringens type B. These data contribute to improve process for industrial toxin production allowing better condition to produce a toxoid vaccine.

MeSH terms

  • Bacterial Toxins / biosynthesis*
  • Bacterial Toxins / immunology
  • Bacterial Vaccines / immunology*
  • Clostridium perfringens / growth & development*
  • Clostridium perfringens / immunology
  • Clostridium perfringens / metabolism
  • Culture Media
  • Veterinary Medicine*

Substances

  • Bacterial Toxins
  • Bacterial Vaccines
  • Culture Media